SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Coliseum Capital Management, LLC, et al. – ‘4’ for 9/3/20 re: ModivCare Inc.

On:  Tuesday, 9/8/20, at 5:01pm ET   ·   For:  9/3/20   ·   Accession #:  899243-20-24570   ·   File #:  1-34221

Previous ‘4’:  ‘4’ on 6/19/20 for 6/17/20   ·   Next:  ‘4’ on 9/16/20 for 9/14/20   ·   Latest:  ‘4’ on 4/22/24 for 4/18/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/08/20  Coliseum Capital Management, LLC  4                      1:20K  Providence Service Corp.          Donnelley Fin’l S… 06/FA
          Shackelton Christopher S
          Coliseum Capital, LLC
          Coliseum Capital Partners, L.P.
          Coliseum Capital Partners II, L.P.
          Gray Adam
          Coliseum Capital Co-Invest, L.P.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      3K


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Form 4 Submission
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Coliseum Capital Management, LLC
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
PROVIDENCE SERVICE CORP [ PRSC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
9/3/20
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 9/3/20C 418 (1) (2)A (1) (2)1,795,076ISee Footnotes (3) (4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series A Convertible Preferred Stock (5) 9/3/20S 27,509 (6) (6)Common Stock68,979$209.88 (5)167ISee Footnotes (3) (4)
Series A Convertible Preferred Stock (1) (2) 9/3/20C 167 (2) (6) (6)Common Stock418$0.00 (2)0 (7)ISee Footnotes (3) (4) (8)
1. Name and Address of Reporting Person*
Coliseum Capital Management, LLC
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Shackelton Christopher S
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Coliseum Capital, LLC
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
1. Name and Address of Reporting Person*
COLISEUM CAPITAL PARTNERS, L.P.
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Coliseum Capital Partners II, L.P.
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Gray Adam
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Coliseum Capital Co-Invest, L.P.
(Last)(First)(Middle)
105 ROWAYTON AVE.
(Street)
ROWAYTONCT06853
(City)(State)(Zip)
Explanation of Responses:
(1)  On September 3, 2020, the Issuer elected to effect the conversion (the "Conversion") of all outstanding shares of its Series A Convertible Preferred Stock, par value $0.001 per share ("Series A Preferred Stock"), pursuant to the certificate of designation for the Series A Preferred Stock (the "COD"). As a result of the Conversion, 167 shares of Series A Preferred Stock held by the Holders (defined below) were converted into shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") at the conversion rate of 2.507523 shares of Common Stock for each share of Series A Preferred Stock and cash-in-lieu of fractional shares.
(2)  The Conversion of 167 shares of Series A Preferred Stock is reported for purposes of Form 4 as the disposition of the Series A Preferred Stock and the acquisition of the underlying 418 shares of Common Stock.
(3)  The Common Stock is held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, (c) Coliseum Capital Co-Invest, L.P. ("CCC"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (d) a separate account investment advisory client of CCM (the "Separate Account"; collectively with CCP, CCP2, CCC, the "Holders").
(4)  Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC and may be deemed to have an indirect pecuniary interest in the securities held by the CCP, CCP2, CCC and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from CCP, CCP2 and CCC. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC, CCM and CCC disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.
(5)  In accordance with that certain Preferred Stock Conversion Agreement, dated June 8, 2020 (as amended by that certain Amendment to Preferred Stock Conversion Agreement, dated as of September 2, 2020, the "Conversion Agreement"), immediately prior to the Conversion, the Issuer repurchased 27,509 shares of Series A Preferred Stock held by the Holders in the aggregate for (i) a cash amount equal to $209.88 per share of Series A Preferred Stock plus (ii) a cash amount equal to accrued but unpaid dividends on such shares through the day prior to September 3, 2020.
(6)  Pursuant to the COD, each share of Series A Preferred Stock held by the Holders will be convertible, at the option of the Holders, into shares of Common Stock. The Holders acquired 91,800 shares of Series A Preferred Stock on 2/2/15, 524,116 shares of Series A Preferred Stock on 2/11/15, and 150,000 shares of Series A Preferred Stock on 3/12/15, of which 369,120 shares of Series A Preferred Stock were converted in to Common Stock on 6/11/20, and an additional 369,120 shares of Series A Preferred Stock were purchased by the Issuer on 6/11/20. The Series A Preferred Stock has no expiration date, except upon the occurrence of a Change of Control (as defined in the COD).
(7)  The Conversion of shares of Series A Preferred Stock, as described in footnote (1) above, occurred after the sale of shares of Series A Preferred Stock by the Holders, as described in footnote (5) above.
(8)  Following the transactions reported herein, CCP, CCP2, CCC and the Separate Account no longer directly beneficially own any shares of Series A Preferred Stock. Further, CCP, CCP2, CCC and the Separate Account directly beneficially owned the Common Stock as follows: 877,795; 261,300; 253,021; and 402,960 shares, respectively.
Remarks:
Shackelton is a director of the Issuer. As a result, the following persons may be deemed directors by deputization of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended: CCM; CC; CCP; CCP2; CCC; and Gray.
Coliseum Capital Management, LLC, By: /s/ Chivonne Cassar, Attorney-in-fact 9/8/20
Christopher Shackelton, By: /s/ Chivonne Cassar, Attorney-in-fact 9/8/20
Coliseum Capital, LLC, By: /s/ Chivonne Cassar, Attorney-in-fact 9/8/20
Coliseum Capital Partners, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Chivonne Cassar, Attorney-in-fact 9/8/20
Coliseum Capital Partners II, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Chivonne Cassar, Attorney-in-fact 9/8/20
Adam Gray, By: /s/ Chivonne Cassar, Attorney-in-fact 9/8/20
Coliseum Capital Co-Invest, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Chivonne Cassar, Attorney-in-fact 9/8/20
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Codes:
    C    Conversion of derivative security.
    S    Open market or private sale of non-derivative or derivative security.

↑Top
Filing Submission 0000899243-20-024570   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., Apr. 25, 3:22:47.2pm ET